For people with aneurysmal subarachnoid hemorrhage and anemia, there was no significant neurological benefit from getting red ...
The hallmark symptom of sickle cell anemia is pain, particularly episodes of sudden pain, sometimes called sickle cell crises ...
Beam Therapeutics (BEAM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst Yanan Zhu ...
SAN DIEGO -- Treatment with hydroxyurea led to more hematologic dose-limiting toxicities (DLTs) compared with placebo in ...
"The education was not there. It still isn't there, but it should be," Alvin Henry Jr., a sickle cell disease patient, said. ...
The majority of SCD patients given Lyfgenia in clinical trials remained free of vaso-occlusive events (VOEs) following ...
AABB guidelines overall favor a restrictive transfusion strategy, recommending RBC transfusion for hemoglobin <7 g/dL for the ...
Sotagliflozin, a dual SGLT1/2 inhibitor, increased hemoglobin levels in patients with type 2 diabetes and chronic kidney ...
J&J aims to expand Darzalex's use even further in the blood cancer, while Merck & Co. and Novo Nordisk presented at ASH ...
Complete SAD/MAD data from the Phase 1 trial of DISC-3405 in healthy volunteers were presented. In the SAD portion of this trial, healthy males and females ages 18 to 65 were given a single dose of ...
Promising topline results from a phase 3B study show the efficacy and quality of life (QOL) improvements of iptacopan ...